AI assistant
RESMED INC — Director's Dealing 2012
Jan 3, 2012
65715_rns_2012-01-03_d3fae308-5d97-4f47-a07c-450023ba820a.pdf
Director's Dealing
Open in viewerOpens in your device viewer
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
OMB APPROVAL
OMB Number: 3235-0287 Expires: December 31, 2011 Estimated average burden hours per response 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
| 1. Name and Address of Reporting Person * | 2. Issuer Name and Ticker or Trading Symbol | 5. Relationship of Reporting Person(s) to Issuer (Checkall applicable) | |||
|---|---|---|---|---|---|
| FARRELL PETER C | RESMED INC [RMD] | ||||
| (Last) (First) (Middle)ResMed Inc.9001 Spectrum Center Boulevard | 3. Date of Earliest Transaction (Month/Day/Year)12/27/2011 | Director10% OwnerOfficerOther(give title below)(specify below)Executive Chairman and CEO | |||
| (Street)San DiegoCA 92123(City) (State) (Zip) | 4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing(Check Applicable Line) | |||
| Form filed by One Reporting PersonForm filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
| 1.Title of Security2. Transaction Date2A. Deemed Execution(Instr. 3)(Month/Day/Year)Date, if any(Month/Day/Year) | 3.TransactionCode(Instr. 8) | 4. Securities Acquired(A) or Disposed Of (D)(Instr. 3, 4 and 5) | 5. Amount ofSecuritiesBeneficially OwnedFollowing Reported | 6. OwnershipForm: Direct(D) or Indirect(I) (Instr. 4) | 7. Nature ofIndirectBeneficialOwnership | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Code | V | Amount | (A)or(D) | Price | Transaction(s)(Instr. 3 and 4) | (Instr. 4) | ||||
| ResMed Common Stock | 12/27/2011 | G | 200,000(1) | D | $ 0 | 526,959 | D | |||
| ResMed Common Stock | 3,317 | I | Peter C. FarrellApril 2010Annuity Trust | |||||||
| ResMed Common Stock | 21,391 | I | Peter C. FarrellJuly 2010Annuity Trust | |||||||
| ResMed Common Stock | 200,000 | I | Peter C. FarrellDecember2010 AnnuityTrust | |||||||
| ResMed Common Stock | 200,000 | I | Peter C. FarrellAugust 2011Annuity Trust | |||||||
| ResMed Common Stock | 200,000 | I | Peter C. FarrellDecember |
| 2011 Annuity | |||||
|---|---|---|---|---|---|
| Trust |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
| 1. Title ofDerivativeSecurity(Instr. 3) | 2.Conversionor ExercisePrice ofDerivativeSecurity | 3.TransactionDate(Month/Day/ Year) | 3A. DeemedExecutionDate, if any(Month/Day /Year) | 4.TransactionCode (Instr.8) | DerivativeSecuritiesor Disposed3, 4 and 5) | 5. Number ofAcquired (A)of (D) (Instr. | Expiration Date(Month/ Day /Year) | 6. Date Exercisable and | 3 and 4) | 7. Title andAmount ofSecuritiesUnderlyingDerivativeSecurity (Instr. | 8. Price ofDerivativeSecurity(Instr. 5) | 9. Number ofDerivativeSecuritiesBeneficiallyOwnedFollowingReported | 10.OwnershipForm ofDerivativeSecurity:Direct(D) orIndirect (I) | 11. Natureof IndirectBeneficialOwnership(Instr. 4) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Code | V (A) | (D) | DateExercisable | ExpirationDate(Month/Day/Year) | Title AmountorNumberof Shares | Transaction(s)(Instr. 4) | (Instr. 4) |
Explanation of Responses:
- Transaction represents a gift from the Peter C. Farrell Trust to fund the Peter C. Farrell December 2011 Annuity Trust. Dr. Farrell is the trustee of his personal trust, but is not the trustee of the Annuity Trust. Per the terms of the Annuity Trust, 90% of the original value will be transferred to Dr. Farrell at the end of the Trust's first year.
| Peter C. Farrell | 12/29/2011 |
|---|---|
| ** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.